An fMRI Study Of Brain Response In Patients With Fibromyalgia

Completed · Phase 1 · Has a placebo group

Conditions studied: Fibromyalgia

In brief

The purpose of this study is to explore how pregabalin works in patients with fibromyalgia by evaluating brain imaging signals. To find out whether fMRI (functional magnetic resonance imaging) is an efficient way to show whether new pain medications are effective in treating fibromyalgia.

Key facts

Study ID

NCT00760474

Run by

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

People needed

27

Starts

2009-01-01

Expected to finish

2011-03-01

Last updated by the study team

2021-01-22

Who can join

Age: 18 and older, up to 70. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Women must have pain due to fibromyalgia
• Fibromyalgia must have been diagnosed at least 6 months prior to be eligible for this study

You may not qualify if…

• Patients with severe depression or other serious illness, who are left-handed, or who are pregnant or nursing are not eligible for this study.

Where it is running

• Pfizer Investigational Site — Ann Arbor, Michigan, United States
• Pfizer Investigational Site — Ann Arbor, Michigan, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.